Seeing Is Believing

Currently out of the existing stock ratings of Derek Archila, 174 are a BUY (62.59%), 97 are a HOLD (34.89%), 7 are a SELL (2.52%).
Analyst Derek Archila, currently employed at WELLS FARGO, carries an average stock price target met ratio of 51.54% that have a potential upside of 45% achieved within 147 days.
Derek Archila’s has documented 541 price targets and ratings displayed on 49 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on ZYME, Zymeworks Common Stock at 23-Oct-2025.
Analyst best performing recommendations are on EQ (EQUILLIUM).
The best stock recommendation documented was for EQ (EQUILLIUM) at 7/10/2020. The price target of $10 was fulfilled within 3 days with a profit of $6.81 (213.48%) receiving and performance score of 711.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$18
5 years 1 months 29 days ago
(31-Aug-2020)
3/3 (100%)
$3.19 (21.54%)
78
Hold
$60
5 years 1 months 29 days ago
(30-Aug-2020)
0/19 (0%)
$41.31 (221.03%)
Hold
$34.5
$0.01 (0.03%)
$66
5 years 1 months 29 days ago
(30-Aug-2020)
1/8 (12.5%)
$0.28 (0.82%)
39
Hold
$34.5
$0.01 (0.03%)
$14
5 years 1 months 29 days ago
(30-Aug-2020)
7/7 (100%)
$0.28 (0.82%)
105
Hold
$35
$0.51 (1.48%)
$24
5 years 1 months 29 days ago
(30-Aug-2020)
7/17 (41.18%)
$0.78 (2.28%)
376
Which stock is Derek Archila is most bullish on?
Which stock is Derek Archila is most reserved on?
What Year was the first public recommendation made by Derek Archila?